These data indicated that macrophages with FABP4‐knockdown promoted CD80+CCR7+ phenotype and exerted the tumor‐inhibiting effect through NF‐κB/RelA‐mediated IL1α regulation. This evidence concerns the gene CD80 and neoplasm.